Improved insulin sensitivity in 80 nondiabetic patients with MDD after clinical remission in a double-blind, randomized trial of amitriptyline and paroxetine.
about
Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of AssaysMetabolic Effects of Antidepressant TreatmentTreatment with an SSRI antidepressant restores hippocampo-hypothalamic corticosteroid feedback and reverses insulin resistance in low-birth-weight ratsHigh fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice.Depressive symptoms, antidepressant medication use, and insulin resistance: the PPP-Botnia StudyPlasma biomarkers of depressive symptoms in older adults.First quantitative high-throughput screen in zebrafish identifies novel pathways for increasing pancreatic β-cell mass.Cardiometabolic effects in caregivers of nursing home placement and death of their spouse with Alzheimer's diseaseInsulin Signaling in Bupivacaine-induced Cardiac Toxicity: Sensitization during Recovery and Potentiation by Lipid EmulsionDepression, depression treatment, and insulin sensitivity in adults at risk for type 2 diabetes.The risk of new-onset diabetes in antidepressant users - A systematic review and meta-analysisComment on Vimalananda et al. Depressive symptoms, antidepressant use, and the incidence of diabetes in the Black Women's Health Study. Diabetes Care 2014;37:2211-2217.The Impact of Antidepressant Therapy on Glycemic Control in Canadian Primary Care Patients With Diabetes Mellitus.Effect of collaborative depression treatment on risk for diabetes: A 9-year follow-up of the IMPACT randomized controlled trial
P2860
Q28546583-3C402FDB-090F-4B3D-BC81-4ABFCE2ABA5BQ33712365-9DEF1A9F-6733-4E7D-AE46-9CCAFC36BBAFQ33840356-66042B8B-16DE-44D0-9462-742C037A5748Q33850466-1E406798-0C4B-4FCA-8772-2F50EE27764EQ35563603-B4E5A78B-580D-47BF-8512-656A6089F067Q35844316-A0A6714E-A572-4F73-84E4-CED338CB34F4Q35947964-47C04C90-1561-4FA4-BFA1-99863987D892Q36063671-6EB59718-40AB-464B-A5FE-0AFE66497111Q36479719-72207627-806D-43C2-84E2-41BC67AD0CABQ37384427-BE48D797-7734-4BD5-A290-B692DD0B549EQ41185364-ABF83A76-FB50-4AB2-A71C-6A9F705AFEE0Q43114827-1E2C0D1D-338F-4C29-BA2A-E97CB4FF2160Q55410230-92DD4E8D-1110-4FBD-9036-2A3490A99580Q58715887-9BEF50C9-D706-4AD0-ABFA-3EBEA0302C8F
P2860
Improved insulin sensitivity in 80 nondiabetic patients with MDD after clinical remission in a double-blind, randomized trial of amitriptyline and paroxetine.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Improved insulin sensitivity i ...... amitriptyline and paroxetine.
@en
Improved insulin sensitivity i ...... amitriptyline and paroxetine.
@nl
type
label
Improved insulin sensitivity i ...... amitriptyline and paroxetine.
@en
Improved insulin sensitivity i ...... amitriptyline and paroxetine.
@nl
prefLabel
Improved insulin sensitivity i ...... amitriptyline and paroxetine.
@en
Improved insulin sensitivity i ...... amitriptyline and paroxetine.
@nl
P2093
P356
P1476
Improved insulin sensitivity i ...... f amitriptyline and paroxetine
@en
P2093
Bettina Weber-Hamann
Florian Lederbogen
Isabella Heuser
Maria Gilles
Michael Deuschle
P304
P356
10.4088/JCP.V67N1204
P577
2006-12-01T00:00:00Z